In APP/PS1 transgenic mice, Cd treatment aggravated memory loss, which was accompanied by increases in the number and size of senile plaques, as well as in the overproduction of Aβ (1-42) in the cortex and hippocampus (Li et al., 2012). The gene discussed is APP; the disease is Senile plaques.